Hazelnut and neuroprotection: Improved memory and hindered anxiety in response to intra-hippocampal Aβ injection

Nutritional Neuroscience

Volumn 20, Issue 6, 2017, Pages 317-326

  Bahaeddin, Zahra ^a   Yans, Asal ^a   Khodagholi, Fariba ^a   Hajimehdipoor, Homa ^a   Sahranavard, Shamim ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer's disease; Anxiety; Apoptosis; Hazelnut; Memory; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; NATURAL PRODUCT; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR; NERVE PROTEIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORYLUS AVELLANA; DIET SUPPLEMENTATION; ELEVATED PLUS MAZE TEST; EXPERIMENTAL BEHAVIORAL TEST; HIPPOCAMPUS; MALE; MEMORY DISORDER; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE TEST; POWDER; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; WEIGHT GAIN; WESTERN BLOTTING; WORKING MEMORY; Y-MAZE TEST; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; DISEASE MODEL; ETHNOBOTANY; ETIOLOGY; FUNCTIONAL FOOD; GROWTH, DEVELOPMENT AND AGING; HAZELNUT; HUMAN; IMMUNOLOGY; IRAN; MAZE TEST; MEMORY; METABOLISM; NERVE CELL; NUT; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; RANDOMIZATION; TRADITIONAL MEDICINE; WISTAR RAT;

ALZHEIMER DISEASE; ANIMALS; ANXIETY; APOPTOSIS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CORYLUS; DISEASE MODELS, ANIMAL; ETHNOBOTANY; FUNCTIONAL FOOD; HIPPOCAMPUS; HUMANS; IRAN; MAZE LEARNING; MEDICINE, TRADITIONAL; MEMORY; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTION; NUTS; RANDOM ALLOCATION; RATS, WISTAR;

EID: 84978536225     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1080/1028415X.2015.1126954     Document Type: Article

References (88)

1. Luchsinger JA, Mayeux R., Dietary factors and Alzheimer's disease. Lancet Neurol 2004;3(10):579–87. doi:10.1016/S1474-4422(04)00878-6
2. Dosunmu R, Wu J, Basha MR, Zawia NH., Environmental and dietary risk factors in Alzheimer's disease. Expert Rev Neurother 2007;7(7):887–900.
3. Shah R., The role of nutrition and diet in Alzheimer disease:a systematic review. J Am Med Dir Assoc 2013;14(6):398–402. doi:10.1016/j.jamda.2013.01.014
4. Ahmadian-Attari MM, Mosaddegh M, Kazemnejad A, Noorbala AA., Comparison between complementary dietary treatment of Alzheimer disease in Iranian traditional medicine and modern medicine. Iran J Public Health 2013;42(12):1414–21.
5. Ahmadian-Attari MM, Ahmadiani A, Kamalinejad M, Dargahi L, Shirzad M, Mosaddegh M., Treatment of Alzheimer's disease in Iranian traditional medicine. Iran Red Crescent Med J 2015;17(1):1–7.
6. Chashti HAK., Exir-e-Azam. Tehran:Tehran University of Medical Science, Institute for Islamic and Complementary Medicine; 2007.
7. Rhazes Miz., Al-hawi. Persian translation of the critical arabic text Alhavi Pharmaceutical Company. 1990.
8. Avicenna. Qanun (Canon of Medicine). Tehran:Soroush Press; 2008.
9. Ros E., Health benefits of nut consumption. Nutrients 2010;2(7):652–82. doi:10.3390/nu2070652
10. US Food & Drug Administration. Qualified health claims:letter of enforcement discretion–nuts and coronary heart disease. Rockville, MD:US Food & Drug Administration; 2003;14:1–4.
11. Alasalvar C, Shahidi F., Tree nuts:composition, phytochemicals, and health effects. St. John’s, Newfoundland:CRC Press; 2008.
12. Bhagwat S, Haytowitz DB, Holden JM., USDA database for the flavonoid content of selected foods, Release 3.1. Beltsville:US Department of Agriculture; 2011:03-1.
13. Alzheimer's A., 2015 Alzheimer's disease facts and figures. Alzheimer's Dement 2015;11(3):332. doi:10.1016/j.jalz.2015.02.003
14. Hart D, Craig D, Compton S, Critchlow S, Kerrigan B, McIlroy S, et al. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease. Int J Geriatr Psychiatry 2003;18(11):1037–42. doi:10.1002/gps.1013
15. Desai AK, Grossberg GT., Recognition and management of behavioral disturbances in dementia. Prim Care Companion J Clin Psychiatry 2001;3(3):93. doi:10.4088/PCC.v03n0301
16. Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM., Is Alzheimer's disease a systemic disease? Biochim Biophys Acta (BBA) 2014;1842(9):1340–9. doi:10.1016/j.bbadis.2014.04.012
17. Goldsworthy MR, Vallence A-M., The role of β-amyloid in Alzheimer's disease-related neurodegeneration. J Neurosci. 2013;33(32):12910–1. doi:10.1523/JNEUROSCI.2252-13.2013
18. Yamada K, Nabeshima T., Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther 2000;88(2):93–113. doi:10.1016/S0163-7258(00)00081-4
19. Miguel-Hidalgo JJ, Paul IA, Wanzo V, Banerjee PK., Memantine prevents cognitive impairment and reduces Bcl-2 and caspase 8 immunoreactivity in rats injected with amyloid β 1–40. Eur J Pharmacol 2012;692(1):38–45. doi:10.1016/j.ejphar.2012.07.032
20. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z., MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 2010;1352:255–64. doi:10.1016/j.brainres.2010.07.009
21. Medeiros R, Figueiredo CP, Pandolfo P, Duarte FS, Prediger RD, Passos GF, et al. The role of TNF-α signaling pathway on COX-2 upregulation and cognitive decline induced by β-amyloid peptide. Behav Brain Res 2010;209(1):165–73. doi:10.1016/j.bbr.2010.01.040
22. Zhang Y-Y, Fan Y-C, Wang M, Wang D, Li X-H., Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's disease. Clin Intervent Aging 2013;8:103.
23. Garcia-Osta A, Alberini CM., Amyloid beta mediates memory formation. Learn Memory 2009;16(4):267–72. doi:10.1101/lm.1310209
24. Revest J, Dupret D, Koehl M, Funk-Reiter C, Grosjean N, Piazza P, et al. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Mol Psychiatry 2009;14(10):959–67. doi:10.1038/mp.2009.15
25. Kumar A, Singh A., A review on Alzheimer's disease pathophysiology and its management:an update. Pharmacol Rep 2015;67(2):195–203. doi:10.1016/j.pharep.2014.09.004
26. Jesky R, Hailong C., Are herbal compounds the next frontier for alleviating learning and memory impairments? An integrative look at memory, dementia and the promising therapeutics of traditional Chinese medicines. Phytother Res 2011;25(8):1105–18. doi:10.1002/ptr.3388
27. Paxinos G, Watson C., The rat brain in stereotaxic coordinates. San Diego:Academic Press; 2007.
28. Sarter M, Bodewitz G, Stephens DN., Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology 1988;94(4):491–5. doi:10.1007/BF00212843
29. Sanderson DJ, Good MA, Skelton K, Sprengel R, Seeburg PH, Rawlins JNP, et al. Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice:evidence for a dual-process memory model. Learn Mem 2009;16(6):379–86. doi:10.1101/lm.1339109
30. Davoodi FG, Motamedi F, Akbari E, Ghanbarian E, Jila B., Effect of reversible inactivation of reuniens nucleus on memory processing in passive avoidance task. Behav Brain Res 2011;221(1):1–6. doi:10.1016/j.bbr.2011.02.020
31. Hagenbuch N, Feldon J, Yee BK., Use of the elevated plus-maze test with opaque or transparent walls in the detection of mouse strain differences and the anxiolytic effects of diazepam. Behav Pharmacol 2006;17(1):31–41. doi:10.1097/01.fbp.0000189811.77049.3e
32. Zarrindast MR, Khalifeh S, Rezayof A, Rostami P, Sereshki AA, Zahmatkesh M., Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors. Brain Res 2012;1460:25–32. doi:10.1016/j.brainres.2012.04.036
33. Bradford MM., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72(1):248–54. doi:10.1016/0003-2697(76)90527-3
34. MacGibbon G, Lawlor P, Sirimanne E, Walton M, Connor B, Young D, et al. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res 1997;750(1):223–34. doi:10.1016/S0006-8993(96)01351-0
35. Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, Johnson EM, et al. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 1999;58(9):1020–6. doi:10.1097/00005072-199909000-00012
36. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2:release of cytochrome c from mitochondria blocked. Science 1997;275(5303):1129–32. doi:10.1126/science.275.5303.1129
37. Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, et al. Role of interleukin-1β in postoperative cognitive dysfunction. Ann Neurol 2010;68(3):360–8. doi:10.1002/ana.22082
38. Hu N, Yu J-T, Tan L, Wang Y-L, Sun L, Tan L., Nutrition and the risk of Alzheimer's disease. BioMed Res Int 2013;2013:1–12.
39. Solfrizzi V, Capurso C, D'introno A, Colacicco AM, Santamato A, Ranieri M, et al. Lifestyle-related factors in predementia and dementia syndromes. 2008:133–58.
40. Luchsinger JA, Noble JM, Scarmeas N., Diet and Alzheimer's disease. Curr Neurol Neurosci Rep 2007;7(5):366–72. doi:10.1007/s11910-007-0057-8
41. Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, et al. Nutraceutical properties of Mediterranean diet and cognitive decline:possible underlying mechanisms. J Alzheimer's Dis 2010;22(3):715–40. doi:10.3233/JAD-2010-100942
42. Solfrizzi V, Frisardi V, Capurso C, D'introno A, Colacicco AM, Vendemiale G, et al. Dietary fatty acids in dementia and predementia syndromes:epidemiological evidence and possible underlying mechanisms. Ageing Res Rev 2010;9(2):184–99. doi:10.1016/j.arr.2009.07.005
43. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB., Fruit and vegetable juices and Alzheimer's disease:the kame project. Am J Med 2006;119(9):751–9. doi:10.1016/j.amjmed.2006.03.045
44. Gomez-Pinilla F, Nguyen TT., Natural mood foods:the actions of polyphenols against psychiatric and cognitive disorders. Nutr Neurosci 2012;15(3):127–33. doi:10.1179/1476830511Y.0000000035
45. AqiliKhorasani. Kolasat al-Hikmah. Gom:Esmailian Publication; 2006.
46. Kasikci ES, Emekli-Alturfan E, Yarat A., The effects of Corylus avellana on serum lipid profile and oxidative stress in hyperlipidemic-diabetic rats. Dis Mol Med 2014;2(3):45–50. doi:10.5455/dmm.20140803111541
47. Abeer EE-K, Amr AR., Hypoglycemic effect of hazelnut and its effect on some sex hormones in alloxan induced diabetic in female rats. Pak J Nut 2013;12(3):229–38. doi:10.3923/pjn.2013.229.238
48. Delgado T, Malheiro R, Pereira JA, Ramalhosa E., Hazelnut (Corylus avellana L.) kernels as a source of antioxidants and their potential in relation to other nuts. Ind Crops Prod 2010;32(3):621–6. doi:10.1016/j.indcrop.2010.07.019
49. Oliveira I, Sousa A, Morais JS, Ferreira IC, Bento A, Estevinho L, et al. Chemical composition, and antioxidant and antimicrobial activities of three hazelnut (Corylus avellana L.) cultivars. Food Chem Toxicol 2008;46(5):1801–7. doi:10.1016/j.fct.2008.01.026
50. Miyashita K, Tsubakihara Y, Alasalvar C, editors. Antioxidant and anti-obesity effects of hazelnut polyphenols. 6th International Conference and Exhibition on Nutraceuticals and Functional Foods, Anaheim, USA; 2005.
51. Hajimehdipoor H, Tehranifar T, Shafaroodi H., Acetylcholinesterase inhibitory effect of some medicinal herbs used in Iranian traditional medicine for memory improvement. Global J Bot Sci 2013;1:18–21. doi:10.12974/2311-858X.2013.01.01.3
52. Hashimoto M, Rockenstein E, Crews L, Masliah E., Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromol Med 2003;4(1–2):21–35. doi:10.1385/NMM:4:1-2:21
53. Soldano A, Hassan BA., Beyond pathology:APP, brain development and Alzheimer's disease. Curr Opin Neurobiol 2014;27:61–7. doi:10.1016/j.conb.2014.02.003
54. Harkany T, O'mahony S, Keijser J, Kelly JP, Kónya C, Borostyánkői ZA, et al. β-Amyloid (1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiol Dis 2001;8(4):667–78. doi:10.1006/nbdi.2001.0398
55. Flores-Mateo G, Rojas-Rueda D, Basora J, Ros E, Salas-Salvadó J., Nut intake and adiposity:meta-analysis of clinical trials. Am J Clin Nutr 2013;97(6):1346–55. doi:10.3945/ajcn.111.031484
56. Tan SY, Dhillon J, Mattes RD., A review of the effects of nuts on appetite, food intake, metabolism, and body weight. Am J Clin Nutr 2014;100(Suppl. 1):412S–22S. doi:10.3945/ajcn.113.071456
57. Meydani M, Hasan ST., Dietary polyphenols and obesity. Nutrients 2010;2(7):737–51. doi:10.3390/nu2070737
58. Salim S, Chugh G, Asghar M., Inflammation in anxiety. Adv Protein Chem Struct Biol 2012;88:1–25. doi:10.1016/B978-0-12-398314-5.00001-5
59. Walsh DM, Selkoe DJ., Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004;44(1):181–93. doi:10.1016/j.neuron.2004.09.010
60. Song C, Li X, Leonard BE, Horrobin DF., Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats. J Lip Res 2003;44(10):1984–91. doi:10.1194/jlr.M300217-JLR200
61. Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, et al. Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity. Brain 2008;131(3):651–64. doi:10.1093/brain/awn008
62. Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, et al. Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nat Neurosci 2013;16(9):1291–8. doi:10.1038/nn.3480
63. Tobinick E, Gross H, Weinberger A, Cohen H., TNF-alpha modulation for treatment of Alzheimer's disease:a 6-month pilot study. Medscape Gen Med 2006;8(2):25–30.
64. Chandrashekara S, Jayashree K, Veeranna H, Vadiraj H, Ramesh M, Shobha A, et al. Effects of anxiety on TNF-α levels during psychological stress. J Psychosom Res 2007;63(1):65–9. doi:10.1016/j.jpsychores.2007.03.001
65. Karson A, Demirtaş T, Bayramgürler D, Balcı F, Utkan T., Chronic administration of infliximab (TNF-α Inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic Clin Pharmacol Toxicol 2013;112(5):335–40. doi:10.1111/bcpt.12037
66. Gonzalez P, Machado I, Vilcaes A, Caruso C, Roth G, Schiöth H, et al. Molecular mechanisms involved in interleukin 1-beta (IL-1β)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (α-MSH). Brain Behav Immun 2013;34:141–50. doi:10.1016/j.bbi.2013.08.007
67. Kim S-E, Ko I-G, Kim B-K, Shin M-S, Cho S, Kim C-J, et al. Treadmill exercise prevents aging-induced failure of memory through an increase in neurogenesis and suppression of apoptosis in rat hippocampus. Exp Gerontol 2010;45(5):357–65. doi:10.1016/j.exger.2010.02.005
68. Porter AG, Jänicke RU., Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999;6(2):99–104. doi:10.1038/sj.cdd.4400476
69. Hroudová J, Fišar Z, Raboch J., Mitochondrial Functions in Mood Disorders:InTech; 2013.
70. Einat H, Yuan P, Manji HK., Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene:further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res 2005;165(2):172–80. doi:10.1016/j.bbr.2005.06.012
71. Cui S, Sun Y, Liu C., Effect of bushenyisui formula on brain tissue apoptosis and Bcl-2 in beta-amyloid protein-induced Alzheimer's disease rat models. J Tradit Chin Med 2012;32(4):646–50. doi:10.1016/S0254-6272(13)60086-2
72. Pérez-Jiménez J, Neveu V, Vos F, Scalbert A., Identification of the 100 richest dietary sources of polyphenols:an application of the Phenol-Explorer database. Eur J Clin Nutr 2010;64:S112–S20. doi:10.1038/ejcn.2010.221
73. Choi D-Y, Lee Y-J, Hong JT, Lee H-J., Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Brain Res Bull 2012;87(2):144–53. doi:10.1016/j.brainresbull.2011.11.014
74. Vignes M, Maurice T, Lanté F, Nedjar M, Thethi K, Guiramand J, et al. Anxiolytic properties of green tea polyphenol (−)-epigallocatechin gallate (EGCG). Brain Res 2006;1110(1):102–15. doi:10.1016/j.brainres.2006.06.062
75. Habauzit V, Morand C., Evidence for a protective effect of polyphenols-containing foods on cardiovascular health:an update for clinicians. Ther Adv Chronic Dis 2012;3(2):87–106. doi:10.1177/2040622311430006
76. Shi D, Chen C, Zhao S, Ge F, Liu D, Song H., Effects of walnut polyphenol on learning and memory functions in hypercholesterolemia mice. J Food Nutr Res 2014;2(8):450–6. doi:10.12691/jfnr-2-8-4
77. Dias GP, Cavegn N, Nix A, do Nascimento Bevilaqua MC, Stangl D, Zainuddin MSA, et al. The role of dietary polyphenols on adult hippocampal neurogenesis:molecular mechanisms and behavioural effects on depression and anxiety. Oxid Med Cell Longev 2012;2012:1–18. doi:10.1155/2012/541971
78. Masaki K, Losonczy K, Izmirlian G, Foley D, Ross G, Petrovitch H, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000;54(6):1265–72. doi:10.1212/WNL.54.6.1265
79. Grodstein F, Chen J, Willett WC., High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 2003;77(4):975–84.
80. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002;287(24):3223–9. doi:10.1001/jama.287.24.3223
81. Santos LF, Freitas RL, Xavier SM, Saldanha GB, Freitas RM., Neuroprotective actions of vitamin C related to decreased lipid peroxidation and increased catalase activity in adult rats after pilocarpine-induced seizures. Pharmacol Biochem Behav 2008;89(1):1–5. doi:10.1016/j.pbb.2007.10.007
82. Macpherson H, Ellis KA, Sali A, Pipingas A., Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement. Psychopharmacology 2012;220(2):351–65. doi:10.1007/s00213-011-2481-3
83. Yu B-L, Zhao S-P., Anti-inflammatory effect is an important property of niacin on atherosclerosis beyond its lipid-altering effects. Med Hypotheses 2007;69(1):90–4. doi:10.1016/j.mehy.2006.11.026
84. Weglicki W, Mak I, Kramer J, Dickens B, Cassidy M, Stafford R, et al. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 1996;31(5):677–82. doi:10.1016/S0008-6363(95)00196-4
85. Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 2009;1281:117–27. doi:10.1016/j.brainres.2009.04.010
86. Sher L., Depression and suicidal behavior in alcohol abusing adolescents:possible role of selenium deficiency. Minerva Pediatr 2008;60(2):201–9.
87. Bräuer AU, Savaskan NΕ. Molecular actions of selenium in the brain:neuroprotective mechanisms of an essential trace element. Rev Neurosci 2004;15(1):19–32. doi:10.1515/REVNEURO.2004.15.1.19
88. Vadivel V, Kunyanga CN, Biesalski HK., Health benefits of nut consumption with special reference to body weight control. Nutrition 2012;28(11):1089–97. doi:10.1016/j.nut.2012.01.004